Pharma-Bio CMO Sector Emits Healthy Financial Glow with $830 Million in Active Capital Expansion Projects
Pharma-Bio CMO Sector Emits Healthy Financial Glow with $830 Million in Active Capital Expansion Projects
Attachment: North American CMO Sector Project Spending Analysis
Outsourcing remains an essential component to the drug industry. The most fundamental driver behind the use of CMOs is state-of-the-art process and...
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market
- BMS Investing $400 Million in Dublin Sterile Drug Expansion